ZyVersa Therapeutics

Price & Volume

Stats

52W Range	$0.98-$13.40
Market Cap	$2.6M
Shares Short	38,960

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	$491.97

News

Yahoo Finance • last year

ZyVersa Therapeutics, Inc. Announces Reverse Stock Split and Increase in Authorized Shares of Common Stock

Yahoo Finance • last year

ZyVersa Therapeutics Reports Third Quarter 2023 Corporate Update and Financial Results

Yahoo Finance • last year

ZyVersa Therapeutics Announces Article Published in Peer-Reviewed Biomedical Journal Demonstrating That NLRP3 Inflammasome Inhibition Attenuates Inflammatory Bowel Disease Symptoms in Animal Model

Yahoo Finance • last year

ZyVersa Therapeutics Announces Article in Peer-Reviewed Journal, Ecotoxicology and Environmental Safety, Linking Air Pollution with Development and Progression of Chronic Kidney Disease That Can Be Attenuated by Inhibiting Inflammasome NLRP3 Activation

About

CEO	Mr. Stephen C. Glover
CFO	Mr. Peter Wolfe
Address	2200 N. Commerce Parkway, Weston, FL, United States, 33326
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	7